You are here

Injection with the heroin contaminant MPTP

Document

Parkinson's disease and parkinsonism - Injection with the heroin contaminant MPTP Factor

Last reviewed for CCPS 26 September 2007.

Investigative Documents

Claimant Report - Injection Containing MPTP - Parkinson's Disease and Parkinsonism [CR9162]

Preliminary questions [23253]

23343

there is some evidence that an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) may be a factor in the development or worsening of the condition under consideration.

23346the veteran has established the causal connection between the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and VEA service for Parkinson's disease or parkinsonism.

23347the veteran has established the causal connection between the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and VEA service for the clinical onset of parkinsonism.

23349the veteran has established the causal connection between the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and operational service for the clinical onset of parkinsonism.

or

23350the veteran has established the causal connection between the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and eligible service for the clinical onset of parkinsonism.

or

7334 the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service.

7335

the condition under consideration permanently worsened.

23348the veteran has established the causal connection between the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and VEA service for the clinical worsening of Parkinson's disease or parkinsonism.

23351the veteran has established the causal connection between the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and operational service for the clinical worsening of Parkinson's disease or parkinsonism.

or

23352the veteran has established the causal connection between the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and eligible service for the clinical worsening of Parkinson's disease or parkinsonism.

Clinical onset and operational service [23349]

38596the veteran has parkinsonism.

23410

on operational service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

25075

on operational service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) within the 90 days before the clinical onset of the condition under consideration.

23411

the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) that the veteran received on operational service within the 90 days before the clinical onset of the condition under consideration was due to the veteran's serious default, wilful act or serious breach of discipline.

or

23345

the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a result of an illness or injury which is identifiable.

23353

the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a result of the identified illness or injury within the 90 days before the clinical onset of the condition under consideration.

23355the identified illness or injury as a result of which the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was received is causally related to operational service.

Clinical onset and eligible service [23350]

38596the veteran has parkinsonism.

38680

on eligible service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

38681

as a causal result of eligible service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

38683

as a causal result of eligible service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) within the 90 days before the clinical onset of the condition under consideration.

38686

the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) that the veteran received on eligible service within the 90 days before the clinical onset of the condition under consideration was due to the veteran's serious default, wilful act or serious breach of discipline.

or

23345

the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a result of an illness or injury which is identifiable.

23353

the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a result of the identified illness or injury within the 90 days before the clinical onset of the condition under consideration.

23356the identified illness or injury as a result of which the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was received is causally related to eligible service.

Clinical worsening and operational service [23351]

23410

on operational service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

38682

as a causal result of operational service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

38684

as a causal result of operational service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) within the 90 days before the clinical worsening of the condition under consideration.

38687

the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) that the veteran received on operational service within the 90 days before the clinical worsening of the condition under consideration was due to the veteran's serious default, wilful act or serious breach of discipline.

or

23345

the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a result of an illness or injury which is identifiable.

23354

the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a result of the identified illness or injury within the 90 days before the clinical worsening of the condition under consideration.

23355the identified illness or injury as a result of which the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was received is causally related to operational service.

23357

the clinical onset of the condition under consideration occurred prior to that part of operational service to which the identified illness or injury as a result of which the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was received is causally related.

Clinical worsening and eligible service [23352]

38680

on eligible service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

38681

as a causal result of eligible service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

38685

as a causal result of eligible service, the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) within the 90 days before the clinical worsening of the condition under consideration.

38688

the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) that the veteran received on eligible service within the 90 days before the clinical worsening of the condition under consideration was due to the veteran's serious default, wilful act or serious breach of discipline.

or

23345

the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a result of an illness or injury which is identifiable.

23354

the veteran received an injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) as a result of the identified illness or injury within the 90 days before the clinical worsening of the condition under consideration.

23356the identified illness or injury as a result of which the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was received is causally related to eligible service.

23358

the clinical onset of the condition under consideration occurred prior to that part of eligible service to which the identified illness or injury as a result of which the injection with the heroin-contaminant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was received is causally related.